← Leaderboards
Yuan Yuan
Beckman Research Institute/City Of Hope
$1,423,036
Attributed
$2,591,072
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $483.1K · FY2015–21$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,591,072 · 2
By mechanism
R01$2,336,072 · 1
R03$255,000 · 1
Top collaborators
- Shizhen Emily Wang5 shared
Others in their field
Top investigators on “Chemotherapy”
- George R Seage · Abt Associates, Inc.$223,371,661
- Charles A Coltman · Southwest Oncology Group$170,244,220
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$154,566,243
- Philip J Disaia · University Of California Irvine$115,055,799
- Norman Wolmark · Nsabp Foundation, Inc.$106,367,723
Research focus
ChemotherapyBaseFutureMalignant NeoplasmsBreast Cancer TreatmentBloodMalignant Breast NeoplasmRelapseComplexCcl2 GeneCombinatorialClinical TrialsBreast Cancer CellBreast Cancer PatientConventional TherapyChemotherapeutic AgentCarcinogenesisCellsCcl7 GeneAnticancer TreatmentCell SecretionCc Chemokine Receptor 2Ccl8 GeneCancer Cell
Grant awards (7)
Targeting Chemotherapy-induced Breast Cancer Stemness$443,640
R01 · FY2021 · CA
Targeting Chemotherapy-induced Breast Cancer Stemness$469,370
R01 · FY2020 · CA
Targeting Chemotherapy-induced Breast Cancer Stemness$460,280
R01 · FY2019 · CA
Targeting Chemotherapy-induced Breast Cancer Stemness$479,662
R01 · FY2018 · CA
Targeting Chemotherapy-induced Breast Cancer Stemness$483,120
R01 · FY2017 · CA
Peripheral Blood Biomarkers of Molecular Aging Predicting Chemotherapy Induced Toxicity and Functional Decline in Women 60 and Older with Breast Cancer$127,500
R03 · FY2016 · AG · contact PI
Peripheral Blood Biomarkers of Molecular Aging Predicting Chemotherapy Induced Toxicity and Functional Decline in Women 60 and Older with Breast Cancer$127,500
R03 · FY2015 · AG · contact PI